Hinde El Fatemi Selected Research

Breast Neoplasms (Breast Cancer)

1/2023	Secretory Breast Carcinoma: Report of Two Cases and Literature Review.
1/2023	The Clinicopathological Features and Prognostic Significance of HER2-Low in Early Breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative Breast Cancer Stratified by Hormone Receptor Status.
10/2018	The Assessment of HER2 Gene Status by Fluorescence In Situ Hybridization in Invasive Breast Carcinomas With Equivocal HER2 Immunostaining: Experience From a Single Institution.
12/2012	Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hinde El Fatemi Research Topics

Disease

6	Neoplasms (Cancer) 03/2024 - 12/2012
4	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024
1	Secretory breast carcinoma 01/2023
1	Adenocarcinoma of Lung 01/2022
1	Adenocarcinoma 11/2017
1	Tuberculosis (Tuberculoses) 01/2017
1	Kidney Neoplasms (Kidney Cancer) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 11/2014
1	Neurilemmoma (Schwannoma) 02/2014
1	Necrosis 01/2013
1	Postpartum Hemorrhage 01/2013
1	Rupture 01/2012
1	Stomach Neoplasms (Stomach Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

4	Hormones (Hormone)IBA 01/2023 - 11/2014
2	ErbB Receptors (EGF Receptor)IBA 03/2024 - 01/2022
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 10/2018
2	Proteins (Proteins, Gene)FDA Link 11/2014 - 01/2012
1	Tyrosine Kinase InhibitorsIBA 03/2024
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Estrogens (Estrogen)FDA Link 01/2023
1	human ERBB2 proteinIBA 10/2018
1	Estrogen ReceptorsIBA 10/2018
1	AndrogensIBA 11/2014
1	Secretogranin IIIBA 11/2014
1	S100 Proteins (S 100 Protein)IBA 02/2014
1	Thyroglobulin FDA Link 02/2013
1	Hemostatics (Antihemorrhagics)IBA 01/2013
1	ParaffinIBA 12/2012
1	Phenobarbital (Luminal)FDA Link 12/2012

Therapy/Procedure

2	Nephrectomy 01/2016 - 01/2015
1	Proctectomy 11/2017
1	Adjuvant Chemotherapy 11/2017
1	Aftercare (After-Treatment) 01/2017
1	Lymph Node Excision (Lymph Node Dissection) 01/2016
1	Radiotherapy 01/2015
1	Drug Therapy (Chemotherapy) 01/2015
1	Therapeutics 11/2014
1	Cystectomy 01/2012